Use of atypical antipsychotics in the elderly: a clinical review

Pietro Gareri,¹ Cristina Segura-García,² Valeria Graziella Laura Manfredi,¹ Antonella Bruni,² Paola Ciambrone,² Gregorio Cerminara,² Giovambattista De Sarro,² Pasquale De Fazio<sup>2

1</sup>Elderly Health Care, Azienda Sanitaria Provinciale Catanzaro, Catanzaro, Italy; ²Department of Health Sciences, University “Magna Græcia” of Catanzaro, Catanzaro, Italy

Abstract: The use of atypical antipsychotic drugs in the elderly has become wider and wider in recent years; in fact, these agents have novel receptor binding profiles, good efficacy with regard to negative symptoms, and reduced extrapyramidal symptoms. However, in recent years, the use of both conventional and atypical antipsychotics has been widely debated for concerns about their safety in elderly patients affected with dementia and the possible risks for stroke and sudden death. A MEDLINE search was made using the words elderly, atypical antipsychotics, use, schizophrenia, psychosis, mood disorders, dementia, behavioral disorders, and adverse events. Some personal studies were also considered. This paper reports the receptor binding profiles and the main mechanism of action of these drugs, together with their main use in psychiatry and the possible adverse events in elderly people.

Keywords: atypical antipsychotics, dementia, elderly, psychosis, mood disorders, side effects

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.